Chart of the Week: The Race to the Biomarkers Tipping Point

This week’s Chart of the Week is an interesting one.  We will most likely have a follow up after further analysis of the data from BiomarkerBase.  Basically, the chart shows the total commercial usage of a biomarker by company count since the biomarkers first...

Amplion Announces New Biomarker Usage Feature

Anyone involved in biomarkers knows how imperative it is to stay informed about biomarker developments. Here at Amplion, we aggregate and annotate cutting edge biomarker information and publish it in BiomarkerBase, so you can stay up to date on the clinical biomarker...

Chart of the Week: Celgene Poised to Dominate Personalized Medicine?

In our Charts of the Week over the last several weeks we have been analyzing the use of unique biomarkers by pharmaceutical companies.  We are extending that analysis today with a look at the biomarker discovery activity of pharma companies as compared with the number...